Table 4. Expression of Tra2-beta1, HIF-1a, and VEGF in each group.
| Groups | Tra2-beta1 (M ± SD) | HIF-1a (M ± SD) | VEGF (M ± SD) |
|---|---|---|---|
| Blank control | 1.08±0.13 | 1.12±0.19 | 1.13±0.14 |
| Hypoxia model | 1.89±0.09 | 5.46±1.45a | 3.87±0.32a |
| siTra2-beta1 | 0.22±0.04a,b | 0.97±0.09 | 1.06±0.13 |
| Combined intervention | 0.35±0.07b | 3.43±0.87b,c | 2.87±0.48b,c |
a, P<0.05 compared with the blank control group; b, P<0.05 compared with the hypoxia group; c, P<0.05 compared with the siTra2-beta1 group; combined intervention: built by cobalt dioxide and siRNA. M, mean; SD, standard deviation.